Literature DB >> 30121449

The lack of meaningful association between depression severity measures and neurocognitive performance.

John G Keilp1, Sean P Madden2, Marianne Gorlyn2, Ainsley K Burke2, Maria A Oquendo3, J John Mann2.   

Abstract

BACKGROUND: Neurocognitive deficits are common in depression, but most prior studies have not found strong associations between standard measures of symptom severity and the extent of these neurocognitive deficits. Diagnostic heterogeneity, or the lack of specific questions about neurocognition in these measures, may be undermining these associations.
METHOD: Neuropsychological performance was assessed via 10 tasks in a sample of 262 unmedicated patients with Major Depressive Disorder (MDD) and compared to that in healthy volunteers (n = 140), then correlated with (1) standard measures of depression severity including the Hamilton Depression Rating Scale and Beck Depression Inventory, (2) previously established, factor-analytically derived symptom factors that characterize the heterogeneity of these scales, and (3) a separate measure of cognitive complaint (Cognitive Failures Questionnaire) that was included to address the absence of specific questions about cognition in standard rating scales.
RESULTS: Neurocognitive performance in these unmedicated MDD patients was not significantly associated with either total scores on the depression severity measures, any of their derived symptom factors, or the degree of subjective cognitive complaint - which itself was most strongly associated with mood disturbance. LIMITATIONS: Depressed patients with the most prominent neurovegetative symptoms may be underrepresented in this sample.
CONCLUSIONS: Neurocognitive deficits were only weakly associated with standard depression symptom ratings, and not captured by self-report ratings of cognitive complaint. Neurocognitive deficits appear to be a separate symptom dimension that cannot be inferred from overall depression severity and require their own assessment, given that they have prognostic value for functional outcomes, suicide risk, and differential therapeutics.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30121449     DOI: 10.1016/j.jad.2018.08.034

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Electroconvulsive therapy (ECT) for moderate-severity major depression among the elderly: Data from the pride study.

Authors:  Søren D Østergaard; Maria S Speed; Charles H Kellner; Martina Mueller; Shawn M McClintock; Mustafa M Husain; Georgios Petrides; William V McCall; Sarah H Lisanby
Journal:  J Affect Disord       Date:  2020-05-23       Impact factor: 4.839

2.  Reliability and Validity of THINC-it in Evaluating Cognitive Function of Patients with Bipolar Depression.

Authors:  Weihua Zhang; Na Zhu; Jianbo Lai; Jingjing Liu; Chee H Ng; Jun Chen; Chao Qian; Yanli Du; Chanchan Hu; Jingkai Chen; Jianbo Hu; Zhong Wang; Hetong Zhou; Yi Xu; Yiru Fang; Chuan Shi; Shaohua Hu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-10-21       Impact factor: 2.570

3.  Ketamine vs midazolam: Mood improvement reduces suicidal ideation in depression.

Authors:  Annabella Hochschild; John G Keilp; Sean P Madden; Ainsley K Burke; J John Mann; Michael F Grunebaum
Journal:  J Affect Disord       Date:  2021-12-22       Impact factor: 4.839

4.  Kundalini Yoga for Post-Treatment Lyme Disease: A Preliminary Randomized Study.

Authors:  Lilly Murray; Charles Alexander; Clair Bennett; Mara Kuvaldina; Gurucharan Khalsa; Brian Fallon
Journal:  Healthcare (Basel)       Date:  2022-07-15

5.  Weak associations between depressive symptom severity, depressive symptom clusters, and cognitive performance in young to middle-aged men without clinical depression.

Authors:  Sarah M Szymkowicz; Vonetta M Dotson; Rodney D Vanderploeg
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2020-10-29

Review 6.  Clinical Neuropsychological Evaluation in Older Adults With Major Depressive Disorder.

Authors:  Shawn M McClintock; Lex Minto; David A Denney; K Chase Bailey; C Munro Cullum; Vonetta M Dotson
Journal:  Curr Psychiatry Rep       Date:  2021-07-13       Impact factor: 8.081

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.